anb-002
Recombinant proteinexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started May 2, 2023 (NCT06120582)
Timeline
Indications
Studied for
Mechanism of action
- Coagulation factor IXMODULATOR
F9 modulator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06700096 | Phase 3 | Dec 31, 2024 | Biocad |
| NCT06120582 | Phase 1/Phase 2 (Phase 2) | May 2, 2023 | Biocad |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biocad | For profit | 2 | 2 | 2 | 2023 |
1 organizations
Page 1 / 1